Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with ...

MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 children who were born blind. MeiraGTx is ...

A single injection of a healthy gene allowed blind children to recognize objects, shapes, and even read — offering hope for ...

Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...

The vision of one child with AIPL1-associated severe retinal dystrophy improved from light perception to naming his favourite ...

MeiraGTx Holdings plc announced promising results from a first-in-human study published in The Lancet, involving a gene therapy treatment for children with AIPL1-associated retinal dystrophy ...

Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...

A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic ...

In a groundbreaking medical feat, a team of doctors in London has successfully cured blindness in children suffering from a ...

An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...

Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic ...

The AAV-AIPL1 therapy is designed to address severe sight impairment caused by mutations in the AIPL1 gene. This condition is a form of retinal dystrophy that leads to severe visual impairment ...